Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Point32Health | Hemlibra (emicizumab-kxwh) | New policy |
| Aug 2, 2026 | Point32Health | Hemlibra (emicizumab-kxwh) | New policy |
| Aug 2, 2026 | Point32Health | Hemgenix (etranacogene dezaparvovec-drlb) suspension for injection | New policy |
| Aug 2, 2026 | Point32Health | Hemgenix (etranacogene dezaparvovec-drlb) suspension for injection | New policy |
| Aug 2, 2026 | Point32Health | Haegarda (C1 Esterase Inhibitor Subcutaneous [Human]) | New policy |
| Aug 2, 2026 | Point32Health | HIV Pre-Exposure Prophylaxis (PrEP) Medications | New policy |
| Aug 2, 2026 | Point32Health | HIV Pre-Exposure Prophylaxis (PrEP) Medications | New policy |
| Aug 2, 2026 | Point32Health | Gonadotropin-releasing Hormone (GnRH) Agonists | New policy |
| Aug 2, 2026 | Point32Health | Givlaari (givosiran) | New policy |
| Aug 2, 2026 | Point32Health | Givlaari (givosiran) | New policy |
| Aug 2, 2026 | Point32Health | Gene Therapies for Sickle Cell Disease for RITogether | New policy |
| Aug 2, 2026 | Point32Health | Factor Products | New policy |
| Aug 2, 2026 | Point32Health | Factor Products | New policy |
| Aug 2, 2026 | Point32Health | Exondys51 (eteplirsen) | New policy |
| Aug 2, 2026 | Point32Health | Exondys51 (eteplirsen) | New policy |
| Aug 2, 2026 | Point32Health | Evkeeza (evinacumab-dgnb) | New policy |
| Aug 2, 2026 | Point32Health | Evenity (romosozumab-aqqg) | New policy |
| Aug 2, 2026 | Point32Health | Evenity (romosozumab-aqqg) | New policy |
| Aug 2, 2026 | Point32Health | Erythropoiesis Stimulating Agents | New policy |
| Aug 2, 2026 | Point32Health | Epkinly (epcoritamab-bysp) | New policy |
| Aug 2, 2026 | Point32Health | Epkinly (epcoritamab-bysp) | New policy |
| Aug 2, 2026 | Point32Health | Epioxa (riboflavin 5’-phosphate ophthalmic solution) | New policy |
| Aug 2, 2026 | Point32Health | Enzyme Replacement Therapy for Fabry Disease | New policy |
| Aug 2, 2026 | Point32Health | Enjaymo (sutimlimab-jome) | New policy |
| Aug 2, 2026 | Point32Health | Encelto (revakinagene taroretcel-lwey) | New policy |
| Aug 2, 2026 | Point32Health | Encelto (revakinagene taroretcel-lwey) | New policy |
| Aug 2, 2026 | Point32Health | Elrexfio (elranatamab-bcmm) | New policy |
| Aug 2, 2026 | Point32Health | Elrexfio (elranatamab-bcmm) | New policy |
| Aug 2, 2026 | Point32Health | Elevidys (delandistrogene moxeparvovec-rokl) | New policy |
| Aug 2, 2026 | Point32Health | Crysvita (burosumab-twza) | New policy |
| Aug 2, 2026 | Point32Health | Crysvita (burosumab-twza) | New policy |
| Aug 2, 2026 | Point32Health | Cosela (trilaciclib) | New policy |
| Aug 2, 2026 | Point32Health | Cosela (trilaciclib) | New policy |
| Aug 2, 2026 | Point32Health | Continuous Glucose Monitoring Systems: Freestyle and Dexcom Products | New policy |
| Aug 2, 2026 | Point32Health | Complement Inhibitors | New policy |
| Aug 2, 2026 | Point32Health | Complement Inhibitors | New policy |
| Aug 2, 2026 | Point32Health | Columvi (glofitamab-gxbm) | New policy |
| Aug 2, 2026 | Point32Health | Columvi (glofitamab-gxbm) | New policy |
| Aug 2, 2026 | Point32Health | Cinryze (C1 esterase inhibitor) | New policy |
| Aug 2, 2026 | Point32Health | Cinryze (C1 esterase inhibitor [Human]) | New policy |
| Aug 2, 2026 | Point32Health | Cerezyme (imiglucerase), Elelyso (taliglucerase alfa), VPRIV velaglucerase alfa) | New policy |
| Aug 2, 2026 | Point32Health | Casgevy (exagamglogene autotemcel) | New policy |
| Aug 2, 2026 | Point32Health | Casgevy (exagamglogene autotemcel) | New policy |
| Aug 2, 2026 | Point32Health | Carvykti (ciltacabtagene autoleucel) | New policy |
| Aug 2, 2026 | Point32Health | Carvykti (ciltacabtagene autoleucel) | New policy |
| Aug 2, 2026 | Point32Health | Brixadi (buprenorphine extendedrelease) | New policy |
| Aug 2, 2026 | Point32Health | Brineura (cerliponase alfa) | New policy |
| Aug 2, 2026 | Point32Health | Breyanzi (lisocabtagene maraleucel) | New policy |
| Aug 2, 2026 | Point32Health | Breyanzi (lisocabtagene maraleucel) | New policy |
| Aug 2, 2026 | Point32Health | Botulinum Toxins | New policy |